Eswatini
33 clinical trials
Find TrialsClinical Trials (33)
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini
A Clinical Study to Assess the Efficacy of Weekly Doxycycline Prophylaxis to Reduce Bacterial Sexually Transmitted Infections (STI) in Young African Women
The Eswatini PRISM Study on Adolescents Living With HIV
Birth Outcomes In Eswatini After Transition To Dolutegravir-Based Treatment
Characteristics and Outcomes of Patients Who Received Etravirine and/or Darunavir
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern
Evaluating a New Stool Based qPCR for Diagnosis of Tuberculosis in Children and People Living With HIV
Phase 2b, Open Label, Multisite, Randomized Crossover Study of DPP Versus 2PR
Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
The Eswatini Study on Neurocognitive Performance in Adolescents Living With HIV
Eswatini Ring Study: Increasing PrEP Options for Women
Strengthening Primary Healthcare Delivery for Diabetes and Hypertension in Eswatini
A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women
Antenatal Depression Help-seeking Trial in Eswatini
Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and Death
Swaziland HIV Incidence Measurement Survey 2